Emtora Biosciences Company
Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug.
Technology:
United States
Industry:
Longevity
Headquarters:
San Antonio, Texas, United States
Founded Date:
2012-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
2
Total Funding:
$23,826,094
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-08-19
Last Funding Type:
Grant
Register and Claim Ownership